Residency · Residency · General Surgery

Nutrition in the Surgical Patient

Overview

Malnutrition affects 30 to 50% of hospitalized surgical patients and is an independent risk factor for postoperative complications, prolonged length of stay, and mortality. Appropriate nutritional assessment and timely intervention are essential components of perioperative care, and the surgeon who understands the metabolic response to injury and the principles of nutritional support can make decisions that meaningfully improve outcomes.

Nutritional Assessment

Clinical Indicators of Malnutrition

Several clinical markers help identify the malnourished surgical patient. Unintentional weight loss exceeding 10% over six months or 5% over one month is a red flag, as is a BMI below 18.5. Reduced oral intake -- defined as less than 50% of estimated requirements for more than seven days -- should prompt concern. On examination, muscle wasting, temporal wasting, loss of subcutaneous fat, and functional decline (assessed by grip strength) all point toward significant nutritional deficiency.

Laboratory Markers

Among these markers, an albumin below 3.0 g/dL stands out as the single strongest predictor of postoperative morbidity and mortality in surgical patients, as demonstrated by NSQIP data. However, all of these markers are negative acute phase reactants, meaning they drop during inflammation and stress regardless of nutritional status -- interpretation must always account for the inflammatory context, and correlation with C-reactive protein is helpful. Nitrogen balance, calculated as nitrogen intake minus nitrogen output (where nitrogen output equals 24-hour urine urea nitrogen plus 4 grams for insensible losses), provides a dynamic assessment of protein metabolism.

Screening Tools

Validated screening tools help identify patients at nutritional risk. The Nutrition Risk Screening tool (NRS-2002), recommended by ESPEN, flags patients with a score of 3 or higher as nutritionally at risk. The Subjective Global Assessment (SGA) combines history and physical examination findings into a practical bedside tool, while the Malnutrition Universal Screening Tool (MUST) offers another validated approach.

Metabolic Response to Surgery and Stress

The body's metabolic response to surgical injury occurs in two distinct phases. The ebb phase, spanning the first 24 hours after injury, is characterized by decreased metabolic rate, decreased cardiac output, and decreased oxygen consumption, accompanied by a surge of counter-regulatory hormones including cortisol, catecholamines, and glucagon.

The flow phase follows at 24 to 72 hours and represents a hypermetabolic state with increased metabolic rate, oxygen consumption, and cardiac output. Catabolism dominates as skeletal muscle proteolysis provides amino acids for gluconeogenesis and acute phase protein synthesis. Insulin resistance drives hyperglycemia as part of the stress response. The magnitude of increased energy expenditure depends on the insult: elective surgery raises expenditure by 10 to 15%, while major trauma, burns, and sepsis can increase it by 40 to 100%.

An important distinction exists between simple starvation and stressed starvation. In simple starvation, the body adapts by using ketones from fat as its primary fuel, relatively sparing protein and decreasing overall metabolic rate. In stressed starvation -- the state produced by surgery, trauma, and sepsis -- protein catabolism is accelerated, the body cannot effectively adapt to ketone utilization, and exogenous nutrition can attenuate but never abolish the catabolic response.

Caloric and Protein Requirements

Energy Requirements

Energy requirements can be estimated using the Harris-Benedict equation for basal energy expenditure, multiplied by a stress factor of 1.2 to 1.5. As a practical estimate, most surgical patients need 25 to 30 kcal/kg/day. Indirect calorimetry, which measures resting energy expenditure directly, is the gold standard for ICU patients. A critical principle is that overfeeding is harmful: excess calories cause hyperglycemia, hepatic steatosis, and increased carbon dioxide production, which may prolong ventilator weaning. Non-protein calories should be distributed as a mix of carbohydrate (60 to 70%) and fat (30 to 40%).

Protein Requirements

Protein needs vary with clinical context:

Each gram of nitrogen is equivalent to 6.25 grams of protein.

Enteral Nutrition

Advantages Over Parenteral Nutrition

Enteral nutrition is always preferred when the gut is functional -- the old adage "if the gut works, use it" remains a cornerstone of surgical nutrition. Enteral feeding maintains gut mucosal integrity and barrier function, preserves gut-associated lymphoid tissue (GALT) and secretory IgA, reduces bacterial translocation, results in fewer infectious complications, and is substantially less expensive than parenteral nutrition.

Timing

Early enteral nutrition, initiated within 24 to 48 hours postoperatively, is recommended for most surgical patients. A critical point that trainees must internalize is that clinicians should not wait for bowel sounds, flatus, or a bowel movement before initiating enteral feeding -- multiple meta-analyses have demonstrated that early enteral nutrition reduces infectious complications and length of stay.

Routes of Enteral Access

The choice of enteral access route depends on anticipated duration and aspiration risk. Nasogastric tubes are appropriate for short-term use (less than four weeks) but carry aspiration risk. Nasoduodenal or nasojejunal tubes provide post-pyloric feeding and are useful in gastroparesis, severe pancreatitis, and patients at high aspiration risk. For longer-term needs exceeding four weeks, a gastrostomy (PEG or surgical) is preferred when endoscopic access is feasible. A jejunostomy (surgical or PEJ) provides post-pyloric, long-term access with lower aspiration risk and is commonly placed at the time of major upper GI surgery.

Enteral Formulas

Standard polymeric formulas contain intact protein, complex carbohydrates, and long-chain triglycerides and require normal digestion and absorption. Semi-elemental and elemental formulas contain hydrolyzed protein (peptides or free amino acids) and medium-chain triglycerides and are designed for patients with impaired digestion, such as those with short gut syndrome or pancreatitis. Fiber-enriched formulas may help manage diarrhea and promote colonic health. Disease-specific formulas are available for specific clinical scenarios:

Complications of Enteral Nutrition

Aspiration is the most feared complication and is mitigated by maintaining the head of bed at 30 to 45 degrees and checking gastric residual volumes, though the utility of residual volume monitoring is increasingly debated. Diarrhea is the most common complication and should prompt evaluation for C. difficile infection, medication-related causes (particularly sorbitol in liquid elixirs), formula osmolarity, and infusion rate.

Refeeding syndrome is a potentially lethal complication that occurs when severely malnourished patients are fed too rapidly. Carbohydrate reintroduction triggers insulin release, which drives phosphate, potassium, and magnesium intracellularly, causing dangerous extracellular depletion that can lead to cardiac arrhythmias, respiratory failure, and death. Prevention requires starting feeds at a low rate (10 to 15 kcal/kg/day), advancing slowly, supplementing phosphate, potassium, and magnesium prophylactically, and monitoring electrolytes closely. Tube displacement and clogging are managed by regular flushing with water and avoiding the crushing of enteric-coated medications.

Parenteral Nutrition

Indications

Parenteral nutrition is reserved for patients with a non-functioning GI tract for seven or more days (or when this duration is anticipated) and those unable to meet nutritional goals enterally. Common indications include high-output enterocutaneous fistula, short bowel syndrome, severe ileus, bowel obstruction, and mesenteric ischemia.

Components

Total parenteral nutrition consists of several components. Dextrose provides 3.4 kcal/g as the primary carbohydrate source, with a maximum oxidation rate of approximately 4 to 5 mg/kg/min. Amino acids provide 4 kcal/g and are typically dosed at 1.2 to 1.5 g/kg/day. Lipid emulsions provide 9 kcal/g and supply essential fatty acids; options include soybean oil-based formulations (Intralipid) and mixed oil formulations (SMOFlipid), limited to less than 1 g/kg/day and infused over at least 12 hours. Electrolytes, vitamins, trace elements, and insulin for glycemic control are added to the TPN bag daily.

Routes

Central TPN is administered via a central venous catheter (PICC, subclavian, or internal jugular) and can accommodate solutions with osmolality exceeding 900 mOsm/L and dextrose concentrations up to 25 to 35%. Peripheral parenteral nutrition (PPN) is limited to solutions with osmolality below 900 mOsm/L and dextrose concentrations below 10%, cannot meet full caloric needs, and serves only as a short-term bridge.

Complications of Parenteral Nutrition

Line-related complications include central line-associated bloodstream infection (the most common serious complication), thrombosis, and pneumothorax. Metabolic complications include hyperglycemia, hypertriglyceridemia, electrolyte abnormalities, and refeeding syndrome. Hepatobiliary complications -- including TPN-associated cholestasis and steatosis, acalculous cholecystitis, and hepatic dysfunction with long-term use -- are particularly important. Prevention strategies include cycling TPN (12 to 14 hours on, 10 to 12 hours off), limiting soybean-based lipid, using fish oil-based lipid emulsions (Omegaven), and providing even small amounts of enteral nutrition when possible. Essential fatty acid deficiency manifests as dry, flaky skin, alopecia, and poor wound healing and is prevented by ensuring at least 4% of calories come from linoleic acid, which requires a minimum of 500 mL of lipid emulsion per week.

Immunonutrition

Several specific nutrients have immunomodulatory properties that are relevant in surgical patients. Arginine is a precursor for nitric oxide, enhances T-cell function and wound healing, but may be harmful in sepsis due to vasodilation. Glutamine, the preferred fuel for enterocytes and immune cells, is conditionally essential in critical illness; however, the REDOXS trial demonstrated harm with glutamine supplementation in ICU patients with multi-organ failure, and its routine use has fallen out of favor. Omega-3 fatty acids (EPA and DHA) have anti-inflammatory properties and may reduce the systemic inflammatory response. Nucleotides support rapidly dividing cells including immune cells and enterocytes.

Meta-analyses have shown that immunonutrition formulas (such as IMPACT) reduce infectious complications and shorten length of stay in elective GI cancer surgery. However, arginine-supplemented formulas should be avoided in patients with active sepsis.

<image>Flowchart algorithm for nutritional support decision-making in the surgical patient. Start with nutritional risk assessment (NRS-2002), then determine if GI tract is functional. If yes, proceed to enteral nutrition pathway (oral supplements, NG/NJ tube, PEG/PEJ) with route selection based on aspiration risk and duration. If no, proceed to parenteral nutrition pathway (PPN vs central TPN). Include timing recommendations and monitoring parameters at each step.</image>

<image>Anatomical diagram showing different enteral access routes: nasogastric tube, nasoduodenal tube, nasojejunal tube, percutaneous endoscopic gastrostomy (PEG), surgical gastrostomy, and needle catheter jejunostomy (NCJ). Show the stomach and small bowel with tube tip positions clearly labeled. Include indications and contraindications for each route in a sidebar table.</image>

<image>Pathophysiology diagram of refeeding syndrome showing the metabolic cascade: malnourished state with depleted intracellular stores, followed by carbohydrate reintroduction triggering insulin release, which drives phosphate, potassium, and magnesium into cells, causing dangerous extracellular depletion. Show downstream consequences including cardiac arrhythmias, respiratory failure, rhabdomyolysis, and seizures. Include a prevention checklist panel.</image>

Clinical Pearls

Albumin below 3.0 g/dL is the single best predictor of postoperative morbidity and mortality, but it reflects inflammation as much as nutrition. The principle "if the gut works, use it" means enteral nutrition is always preferred over parenteral when feasible. Early enteral feeding within 24 to 48 hours is safe and beneficial, and clinicians should not wait for bowel function to resume. Refeeding syndrome can be fatal, so severely malnourished patients should be started at 10 to 15 kcal/kg/day with prophylactic supplementation of phosphate, potassium, and magnesium. Severely malnourished patients with albumin below 3.0 or weight loss exceeding 10% benefit from 7 to 14 days of preoperative nutritional optimization before elective surgery, even if this means delaying the operation. TPN-associated liver disease is the most common reason for intestinal transplant referral in patients with short bowel syndrome. Glutamine supplementation was once routine in ICU patients but is now considered potentially harmful in those with multi-organ failure based on the REDOXS trial. Overfeeding is as dangerous as underfeeding, as excess dextrose causes hyperglycemia, hepatic steatosis, and increased carbon dioxide production that can impair ventilator weaning. Gastric residual volume monitoring is increasingly considered unreliable and unnecessary. Triglyceride levels should be checked weekly in patients receiving intravenous lipid emulsion, and lipid should be held if levels exceed 400 mg/dL.

References

• McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient (ASPEN/SCCM). JPEN. 2016;40(2):159-211.
• Weimann A, Braga M, Carli F, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017;36(3):623-650.
• Heyland DK, Elke G, Cook D, et al. Glutamine and antioxidants in the critically ill patient (REDOXS trial). N Engl J Med. 2013;368(16):1489-1497.
• Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74(4):534-542.

Read this lecture as Markdown